Bin Zheng
Director/Board Member at Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Profile
Bin Zheng is an Independent Director who currently holds a position at Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
He previously held the same position at Nations Technologies, Inc., ENC Digital Technology Co. Ltd., and Tibet Aim Pharm., Inc.
Bin Zheng active positions
Companies | Position | Start |
---|---|---|
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Sihuan Kebao Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical preparations. Its products include nicorandil for injection, terbutaline sulfate for injection, troxerutin for injection, aminomethylbenzoic acid for injection, isosorbide dinitrate for injection, and olopatadine hydrochloride tablets. The company was founded on December 4, 1998 and is headquartered in Beijing, China. | Director/Board Member | 2021-11-30 |
Former positions of Bin Zheng
Companies | Position | End |
---|---|---|
TIBET AIM PHARM. INC. | Director/Board Member | - |
ENC DIGITAL TECHNOLOGY CO., LTD | Director/Board Member | - |
NATIONS TECHNOLOGIES INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
NATIONS TECHNOLOGIES INC. | Electronic Technology |
TIBET AIM PHARM. INC. | Health Technology |
ENC DIGITAL TECHNOLOGY CO., LTD | Technology Services |
Private companies | 1 |
---|---|
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Sihuan Kebao Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical preparations. Its products include nicorandil for injection, terbutaline sulfate for injection, troxerutin for injection, aminomethylbenzoic acid for injection, isosorbide dinitrate for injection, and olopatadine hydrochloride tablets. The company was founded on December 4, 1998 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Bin Zheng